fda removes tirzepatide says the weight-loss drug shortage is over Article » Proact Pharmacy Services

A licensed physician reviews your weight history, BMI, related conditions, and goals, then writes your starting prescription at 0.25mg weekly

Chief financial officer Yemi Okupe told Bloomberg in an interview published Monday that weight-loss drugs comprised about around 20% of last year's sales

Given the strong association between insulin resistance and the development of metabolic syndrome, enhanced insulin sensitivity through these drugs may reduce visceral fat and decrease inflammation, consequently lowering the risk of metabolic syndrome. While people with obesity or insulin resistance are at higher risk of developing metabolic syndrome, age itself is also a major risk factorand one that, of course, you cant control

Your safety drives that decision, not your previous plan